Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
6
self-reported band not used
Founded
2019
7 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
RELIIS LTD
ABN80644926634
Legal entities
Show as table · Reliis: 1 registry entity
| RELIIS LTD | ABN 80644926634 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Reliis has a clear vision of creating innovative solutions by leveraging safe and effective medicines to address unmet clinical needs, with significant commercial value.
What sets Reliis apart is its strong emphasis on collaboration with renowned medical professionals and clinicians. This distinctive approach, combined with a highly dedicated and knowledgeable team, has established Reliis as an emerging player in the industry.
One of Reliis' key strategies is drug reformulation, which enables a faster and more cost-effective pathway for regulatory approval and commercialisation compared to traditional novel drug development programs.
To ensure the highest level of expertise and insight, Reliis maintains an esteemed Scientific Advisory Board composed of members who actively engage and collaborate with various stakeholders, including medical professionals, researchers, and pharmaceutical experts. By drawing from their practical experience with patients, Reliis' specialist clinicians can identify drugs that enhance patient care and target unmet medical needs.
Currently, Reliis has a robust product pipeline consisting of several high-priority drugs and a medical device. These initiatives highlight Reliis' commitment to advancing healthcare through innovation and addressing critical challenges in patient treatment and care.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU22 Stirling Hwy; Level 1; Nedlands, Western Australia 6009Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under Reliis?
One Western Australia entity on the ABR. RELIIS LTD (ABN 80 644 926 634), high confidence.
How many people work at Reliis?
The record holds 6 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
Where does Reliis have offices?
One address on record, Australia only. Primary: 22 Stirling Hwy, Level 1, Nedlands, Western Australia 6009.
Has Reliis raised funding?
None linked to this brand.
Which companies are listed alongside Reliis?
Eight peer profiles on record: Life Sciences WA and Oqea.